Shares of Syneos Health have moved 0.1% today, and are now trading at a price of $42.62. In contrast, the S&P 500 index saw a -0.0% change. Today's trading volume is 1,574,594 compared to the stock's average volume of 2,719,501.
Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. Based in Morrisville, United States the company has 28,768 full time employees and a market cap of $4,419,729,920.
The company is now trading 0.13% away from its average analyst target price of $42.56 per share. The 9 analysts following the stock have set target prices ranging from $40.0 to $43.0, and on average give Syneos Health a rating of hold.
Over the last 12 months SYNH shares have declined by -39.0%, which represents a difference of -47.0% when compared to the S&P 500. The stock's 52 week high is $71.67 per share and its 52 week low is $22.89. Based on Syneos Health's average net margin growth of 15.1% over the last 4 years, its core business remains strong and the stock price may recover in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-16 | 5,393,082 | 266,497 | 4.94 | 9.78 |
| 2022-02-17 | 5,212,970 | 234,831 | 4.5 | 2.97 |
| 2021-02-18 | 4,415,777 | 192,787 | 4.37 | 55.52 |
| 2020-02-20 | 4,675,815 | 131,258 | 2.81 | n/a |
